|Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?|
A Lonardo, F Nascimbeni, A Mantovani, G Targher
Journal of hepatology 68 (2), 335-352, 2018
|Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis|
A Mantovani, CD Byrne, E Bonora, G Targher
Diabetes care 41 (2), 372-382, 2018
|Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis|
A Mantovani, G Zaza, CD Byrne, A Lonardo, G Zoppini, E Bonora, ...
Metabolism 79, 64-76, 2018
|Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes|
G Targher, A Mantovani, I Pichiri, L Mingolla, V Cavalieri, W Mantovani, ...
Diabetes care 37 (6), 1729-1736, 2014
|Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes|
G Targher, A Mantovani, I Pichiri, R Rigolon, M Dauriz, G Zoppini, ...
Clinical Science 125 (6), 301-310, 2013
|Cardiovascular disease and myocardial abnormalities in nonalcoholic fatty liver disease|
A Mantovani, S Ballestri, A Lonardo, G Targher
Digestive diseases and sciences 61 (5), 1246-1267, 2016
|Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes|
G Targher, F Valbusa, S Bonapace, L Bertolini, L Zenari, I Pichiri, ...
Nutrition, Metabolism and Cardiovascular Diseases 24 (6), 663-669, 2014
|Nonalcoholic fatty liver disease is independently associated with early left ventricular diastolic dysfunction in patients with type 2 diabetes|
A Mantovani, M Pernigo, C Bergamini, S Bonapace, P Lipari, I Pichiri, ...
PLoS One 10 (8), e0135329, 2015
|Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease|
A Mantovani, G Targher
Annals of translational medicine 5 (13), 2017
|Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease|
QM Anstee, A Mantovani, H Tilg, G Targher
Nature Reviews Gastroenterology & Hepatology 15 (7), 425-439, 2018
|Nonalcoholic fatty liver disease is associated with ventricular arrhythmias in patients with type 2 diabetes referred for clinically indicated 24-hour Holter monitoring|
A Mantovani, A Rigamonti, S Bonapace, B Bolzan, M Pernigo, G Morani, ...
Diabetes Care 39 (8), 1416-1423, 2016
|Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus|
S Bonapace, F Valbusa, L Bertolini, I Pichiri, A Mantovani, A Rossi, ...
PLoS One 9 (2), e88371, 2014
|Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals|
A Mantovani, G Zoppini, G Targher, G Golia, E Bonora
Journal of endocrinological investigation 35 (2), 215-218, 2012
|Prognostic impact of diabetes on long-term survival outcomes in patients with heart failure: a meta-analysis|
M Dauriz, A Mantovani, S Bonapace, G Verlato, G Zoppini, E Bonora, ...
Diabetes Care 40 (11), 1597-1605, 2017
|Relationship between non-alcoholic fatty liver disease and psoriasis: a novel hepato-dermal axis?|
A Mantovani, P Gisondi, A Lonardo, G Targher
International journal of molecular sciences 17 (2), 217, 2016
|Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease|
A Mantovani, M Pernigo, C Bergamini, S Bonapace, P Lipari, F Valbusa, ...
Metabolism 64 (8), 879-887, 2015
|Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis|
A Mantovani, M Dauriz, CD Byrne, A Lonardo, G Zoppini, E Bonora, ...
Metabolism 87, 1-12, 2018
|Coronavirus disease 2019 and prevalence of chronic liver disease: A meta‐analysis|
A Mantovani, G Beatrice, A Dalbeni
Liver International, 2020
|Nonalcoholic fatty liver disease (NAFLD) and risk of cardiac arrhythmias: a new aspect of the liver-heart axis|
Journal of clinical and translational hepatology 5 (2), 134, 2017
|Comparison of two creatinine-based estimating equations in predicting all-cause and cardiovascular mortality in patients with type 2 diabetes|
G Targher, G Zoppini, W Mantovani, M Chonchol, C Negri, V Stoico, ...
Diabetes Care 35 (11), 2347-2353, 2012